Rankings
▼
Calendar
IONS FY 2017 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$12B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$514M
+37.9% YoY
Gross Profit
$514M
100.0% margin
Operating Income
$31M
6.0% margin
Net Income
$346,000
0.1% margin
EPS (Diluted)
$-0.05
Cash Flow
Operating Cash Flow
$174M
Free Cash Flow
$136M
Stock-Based Comp.
$86M
Balance Sheet
Total Assets
$1.3B
Total Liabilities
$957M
Stockholders' Equity
$281M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$514M
$373M
+37.9%
Gross Profit
$514M
$373M
+37.9%
Operating Income
$31M
-$20M
+254.0%
Net Income
$346,000
-$60M
+100.6%
← Q4 2016
All Quarters
Q1 2017 →